The commissioner shall adopt rules, pursuant to RSA 541-A, relative to:
I. Identifying communicable diseases to be reported under RSA 141-C:8.
II. The design and content of all forms required under this chapter including forms for reporting communicable diseases under RSA 141-C:8.
III. Reporting required under RSA 141-C:7.
IV. The conduct of investigations carried out under RSA 141-C:9, I.
V. The procedure for disclosure of information under RSA 141-C:10.
VI. Establishing, maintaining, and lifting the isolation and quarantine of cases, carriers, or suspected cases or carriers of communicable diseases under RSA 141-C:11.
VII. Decontamination of commodities, conveyances, baggage, and cargo under RSA 141-C:11, IV.
VIII. Issuing and carrying out orders for the treatment and care and for the restriction and control of diseases under RSA 141-C:15.
IX. Distribution of pharmaceutical agents under RSA 141-C:17.
X. Laboratory testing, fee schedules, and the waiving of fees under RSA 141-C:19.
XI. Regulating use of the common cup under RSA 141-C:4, VIII.
XII. The procedure for written orders under RSA 141-C:12.
XIII. [Repealed.]
XIV. The child's age for administration of a vaccine for immunization.
XV. The number of doses necessary for each vaccine.
XVI. The acceptable level of immunization necessary for a child to be enrolled in a school or child care agency under RSA 141-C:20-a, II(b).
XVII. Procedures for keeping immunization records under RSA 141-C:20-b, II.
XVIII. The immunization registry established under RSA 141-C:20-f.
XIX. Identifying microbial isolates of reportable diseases and patient specimens to be retained or forwarded to the public health laboratories.
XX. Establishing a registry of biological agents present in New Hampshire.
XXI. Procedures relating to information, specimens, and samples as required under RSA 141-C:10, IV.
XXII. Procedures for administration of and disbursement from the mosquito control fund, established in RSA 141-C:25.